Liminal BioSciences Inc.: Liminal BioSciences Regains Compli

LAVAL, QC, Feb. 15, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that it has received written notice from The Nasdaq Stock

Related Keywords

Canada , United Kingdom , Canadian , Dennis Riedl , Kaitlin Gallagher , Shrinal Inamdar , Exchange Commission , Prnewswire Liminal Biosciences Inc , Nasdaq Stock Market , Securities Exchange , Liminal Biosciences Inc , Nasdaq , Nasdaq Capital , Nasdaq Listing Rule , Securities Act , Securities Exchange Act , Canadian Securities Administrators , Annual Report , Liminal Bioscience , Associate Director , Investor Relations , Media Contact , Liminal , Iosciences , Regains , Compliance , Minimum , Price , Requirement ,